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Inclusion criteria 
Studies:  
Randomized controlled trials which had adequately 
concealed the allocation. 
Participants: 
Adults and children with symptoms of cough and 
productive sputum, or with a physician's diagnosis of 
acute bronchitis. 
Intervention: 
Any antibiotic therapy compared with placebo. Other 
drugs, such as analgesics, antitussives, antipyretics, or 
mucolytics, were allowed if both groups had equal 
access. 
Outcomes: 
Time to resolution of cough, sputum production, and 
activity limitations; proportion of participants with 
cough, night cough, productive cough, activity 
limitations, or abnormal lung examination; global 
assessment of improvement by clinicians at follow up; 
and adverse effects. 
Results 
• 13 trials involving 1914 adults and children were 
included. 
• Participants receiving antibiotics had better 
outcomes than those receiving placebo. Antibiotics 
reduced the number of participants at follow up 
with cough (relative risk 0.64, 95% confidence 
interval 0.49 to 0.85); abnormal lung findings (RR 
0.48, 95% CI 0.26 to 0.89); and with no 
improvement on physician assessment (RR 0.52, 
95% CI 0.31 to 0.87). 
• Antibiotics also reduced the duration of cough 
(weighted mean difference 0.58 days, 95% CI 0.01 
to 1.16 days), productive cough (WMD 0.52 days, 
95% CI 0.01 to 1.03 days), and feeling ill (WMD 
0.58 days, 95% CI 0.00 to 1.16 days).  
• No differences between antibiotics and placebo 
detected in the mean duration of activity limitations 
or the presence of night cough, productive cough, 
or activity limitations at follow up. 
• There were more adverse effects with antibiotics, 
but this was not statistically significant (RR 1.22, 
95% CI 0.94 to 1.58). 
Are antibiotics effective for treating acute bronchitis? 
Antibiotics have modest effects for treating patients with acute bronchitis. 
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Authors’ conclusions 
Implications for practice:  
Antibiotics may have beneficial effects in acute bronchitis; however, some of the benefits are slight and need to 
be balanced against costs, adverse effects, and negative effects on antibiotic resistance patterns. There are 
currently few data on the effects of antibiotics in different groups of patients. 
Implications for research: 
Adequately powered, placebo-controlled randomized trials are needed to evaluate which patients are most 
likely to benefit from antibiotic treatment. Patient age, duration and severity of illness, chest examination 
findings, smoking, and other variables may be important considerations in evaluating the effectiveness of 
antibiotics. 
The Cochrane Database of Systematic Reviews is available from www.wiley.com, and free for eligible countries through www.healthinternetwork.org.  
